Abstract
Abstract
Immune thrombocytopenic purpura is an acquired disorder, in which accelerated platelet consumption is due to platelet autoantibodies. The aim of this study was to investigate the clinical value of platelet autoantibodies assay in children with ITP and to evaluate flow cytometry in the detection of platelet autoantibodies in comparison with monoclonal antibody specific immobilization of platelet antigen (MAIPA) assay. We measured platelet autoantibodies by flow cytometry and MAIPA in 18 children with ITP (6 acute, 7 chronic and 5 in remission), in addition to 5 healthy children with matched age and sex as a control group. Significant elevation of platelet-associated immunoglobulin G (PAIgG), PAIgM and PAIgA was demonstrated in children with acute ITP compared to controls and children with chronic ITP (P < 0.05). There was significant elevation of PAIgG and PAIgM in children with acute ITP compared to children with ITP in remission (P < 0.05). There was significant negative correlation between platelet count and PAIgG levels in ITP children (r = −0.717; P = 0.001). Flow cytometry found PAIgG in 94.4% of ITP children. MAIPA has detected platelet specific IgG autoantibodies in 83.3% of ITP children. ROC analysis revealed sensitivity of 94%, specificity of 57% with overall accuracy of 83% for detection of PAIgG by flow cytometry compared to MAIPA.
Conclusions
Platelet autoantibodies testing in ITP can discriminate acute from chronic forms of the disease and is helpful in follow up of patients. Determination of PAIgM in combination of PAIgG could be of interest in the investigation of ITP. Flow cytometry is a sensitive method of detection of platelet autoantibodies that could be used in screening of suspected ITP and should be followed by MAIPA assay in positive cases to establish the diagnosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88:3–40
Kuwana M, Kurata Y, Fujimura K, Fujisawa K, Wada H, Nagasawa T, Nomura S, Kojima T, Yagi H, Ikeda Y (2006) Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi-center prospective study. J Thromb Haemost 4:1936–1943
Smith GA, Ranasinghe E, Ouwehand WH (2007) The importance of using multiple techniques for detection of platelet antibodies. Vox Sang 93:306–308
Rosenfeld GS, Nichols G, Bodensteiner DC (1987) Flow cytometric measurement of antiplatelet antibodies. Am J Clin Pathol 87:518–522
Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C (1987) Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 70:1722–1726
Cines DB, McMillan R (2005) Pathogenesis of chronic immune thrombocytopenic purpura. Curr Opin Hematol 14(5): 511–514
Sinha RK, Kelton JG (1990) Current controversies concerning the measurement of platelet-associated IgG. Transfus Med Rev 4:121–135
Nielsen HE, Andersen EA, Carlsen N, Nir M, Taaning E (2003) Presence of platelet antibodies in idiopathic thrombocytopenic purpura may discriminate acute from chronic disease. Acta Paediatr 92:1208–1210
Fabris F, Scandellari R, Ruzzon E, Randi ML, Luzzatto G, Girolami A (2004) Platelet-associated autoantibodies as detected by a solid-phase modified antigen ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura. Blood 103: 4562–4564
Romero-Guzman LT, Lopez-Karpovitch X, Paredes R, Barrales-Benitez O, Piedras J (2000) Detection of platelet-associated immunoglobulins by flow cytometry for the diagnosis of immune thrombocytopenia: a prospective study and critical review. Haematologica 85:627–631
Zhou J, Liao J, Jiang NG, Kuang LH (2007) Platelet autoantibody and its impact on platelet in patients with idiopathic thrombocytopenic purpura. Sichuan Da Xue Xue Bao Yi Xue Ban 38(6):977–979
Kaplan C, Porcelijn L, Vanlieferinghen P, Julien E, Bianchi F, Martageix C, Bertrand G, Jallu V (2005) Anti-HPA-9bw (Maxa) feto-maternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy, report on eight families. Transfusion 45:1799–1803
Campbell K, Rishi K, Howkins G, Gilby D, Mushens R, Ghevaert C, Metcalfe P, Ouwehand WH, Lucas G (2007) A modified rapid monoclonal antibody-specific immobilization of platelet antigen assay for the detection of human platelet antigen (HPA) antibodies: a multicentre evaluation. VoxSang 93(4):289–297
Berchtold P, Wenger M (1993) Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment. Blood 81:1246–1250
McMillan R, Wang L, Tani P (2003) Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura. J Thromb Haemost 1: 485–491
Fujisawa K, Tani P, Piro L, McMillan R (1993) The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura. Blood 81: 2872–2877
Tomer A (2006) Autoimmune thrombocytopenia: determination of platelet-specific autoantibodies by flow cytometry. Pediatr Blood Cancer 47:697–700
Hézard N, Simon G, Macé C, Jallu V, Kaplan C, Nguyen P (2008) Is flow cytometry accurate enough to screen platelet autoantibodies? Transfusion 48:513–518
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aref, S., Selim, T., Ibrahim, L. et al. Flow cytometry detection of platelets autoantibodies in children with idiopathic thrombocytopenic purpura. Indian J Hematol Blood Transfus 25, 96–103 (2009). https://doi.org/10.1007/s12288-009-0028-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-009-0028-0